Presenter: James M. Greenblatt, MD
Original Date: June 9 2024 

This lecture will shine a focused spotlight on the clinical applications of low-dose lithium, bridging research, concept, and clinical translation with a special focus on Alzheimer’s, suicide prevention, and mood instability/irritability. The talk will begin with a discussion of the evolutionary relationship linking humans and lithium, and the routes through which lithium traverses the food chain to influence human health today. The nuances of the lithium dose-response curve will also be elucidated, distinguishing “nutritional” from “pharmaceutical” dose ranges. Next, a deep dive into the research: what published, peer-reviewed studies from the last half-century reveal about lithium’s effects on mood, cognition, and brain function...as well as its efficacy as an anti-suicide agent.

NUNM is accredited by the North American Naturopathic Continuing Education Council (NANCEAC). This activity qualifies for 1.5 Pharmacology CEUs.